Table 2.

Nutrition and Clinical Characteristics of Patients at Baseline and Time of PS Independence.

Patient	Body Weight			BMI			Plasma Citrulline			Serum Albumina			Serum Creatinineb
Age (y), Sex	BL, kg	EOT, kg	Change From BL, %	BL, kg/m2	EOT, kg/m2	Change From BL, %	BL, µmol/L	EOT, µmol/L	Change From BL, %	BL, g/L	EOT, g/L	Change From BL, %	BL, µmol/L	EOT, µmol/L	Change From BL, %
61, M	76.9	78.3	1.8	26.3	26.8	1.8	20.9	48.9	134.0	39	37	−5.1	151	140	−7.3
54, M	67.2	66.4	−1.3	21.9	21.7	−1.2	27.9	29.1	4.3	45	43	−4.4	106	80	−24.5
46, F	76.6	67.1	−12.4	29.6	25.9	−12.4	20.0	31.1	55.5	41	44	7.3	102	97	−4.9
50, M	74.8	79.3	6.0	26.5	28.1	6.0	17.0	16.7	−1.8	41	45	9.8	106	159	50.0
66, M	68.2	64.5	−5.4	25.4	24.0	−5.4	NA	25.0	NA	33	31	−6.1	71	106	49.3
39, M	63.8	67.0	5.0	22.6	23.7	5.0	12.0	15.4	28.3	47	47	0	74	83	12.2
60, F	64.3	61.2	−4.8	24.2	23.0	−5.0	28.0	25.8	−7.9	42	43	2.4	97	80	−17.5
66, F	48.8	46.0	−5.7	22.0	20.7	−5.7	18.0	43.1	139.4	42	49	16.7	72	78	8.3
46, M	84.6	93.0	9.9	27.9	30.7	9.9	34.0	57.8	70	48	44	−8.3	118	100	−15.3
34, M	67.5	75.3	11.6	24.5	27.3	11.6	20.0	14.2	−29	45	44	−2.2	66	65	−1.5
69, F	79.2	82.0	3.5	29.8	30.9	3.5	21.0	18.4	−12.4	37	47	27.0	53	65	22.6
61, F	51.0	42.7	−16.3	22.0	18.4	−16.4	20.0	40.4	102	38	35	−7.9	88	80	−9.1
63, M	59.0	58.1	−1.5	19.9	19.6	−1.5	11.0	24.1	119.1	40	41	2.5	105	96	−8.6
43, F	87.9	97.7	11.1	30.4	33.8	11.2	13.0	16.6	27.7	32	39	21.9	88	88	0
56, F	62.0	54.0	−12.9	24.5	21.4	−12.9	14.0	41.7	197.9	45	46	2.2	77	70	−9.1
41, F	55.2	56.9	3.1	20	20.6	3.0	28.0	18.4	−34.3	40	42	5	71	62	−12.7

BL, baseline; BMI, body mass index; EOT, end of treatment; F, female; M, male; NA, not available; PS, parenteral support (parenteral nutrition and/or intravenous fluids).

^aReference range, 32–50 g/L.

^bReference range, 40–119 µmol/L.